Diltiazem inhibits breast cancer metastasis via mediating growth differentiation factor 15 and epithelial-mesenchymal transition

Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331:1559–64.

CAS  PubMed  Article  Google Scholar 

Qian C-N, Mei Y, Zhang J. Cancer metastasis: issues and challenges. Chin J Cancer. 2017;36:1–4.

Article  Google Scholar 

Jin L, Han B, Siegel E, Cui Y, Giuliano A, Cui X. Breast cancer lung metastasis: Molecular biology and therapeutic implications. Cancer Biol Ther. 2018;19:858–68.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Scully OJ, Bay B-H, Yip G, Yu Y. Breast cancer metastasis. Cancer Genomics Proteom. 2012;9:311–20.

CAS  Google Scholar 

Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol: Off J Am Soc Clin Oncol. 2006;24:5652–7.

Article  Google Scholar 

Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer. 2008;113:2638–45.

PubMed  Article  Google Scholar 

Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol: Off J Am Soc Clin Oncol. 2008;26:2373–8.

Article  Google Scholar 

Ye X, Brabletz T, Kang Y, Longmore GD, Nieto MA, Stanger BZ, et al. Upholding a role for EMT in breast cancer metastasis. Nature. 2017;547:E1–E3.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ci Y, Zhang Y, Liu Y, Lu S, Cao J, Li H, et al. Myricetin suppresses breast cancer metastasis through down‐regulating the activity of matrix metalloproteinase (MMP)‐2/9. Phytother Res. 2018;32:1373–81.

CAS  PubMed  Article  Google Scholar 

Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, et al. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci. 2011;102:815–27.

CAS  PubMed  Article  Google Scholar 

Wu WS, You RI, Cheng CC, Lee MC, Lin TY, Hu CT. Snail collaborates with EGR-1 and SP-1 to directly activate transcription of MMP 9 and ZEB1. Sci Rep. 2017;7:17753.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Emmerson PJ, Duffin KL, Chintharlapalli S, Wu X. GDF15 and growth control. Front Physiol. 2018;9:1712.

PubMed  PubMed Central  Article  Google Scholar 

Wischhusen J, Melero I, Fridman WH. Growth/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front Immunol. 2020;11:951.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Yang L, Chang C-C, Sun Z, Madsen D, Zhu H, Padkjær SB, et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 2017;23:1158–66.

CAS  PubMed  Article  Google Scholar 

Fang L, Li F, Gu C. GDF-15: a multifunctional modulator and potential therapeutic target in cancer. Curr Pharm Des. 2019;25:654–62.

CAS  PubMed  Article  Google Scholar 

Lu X, He X, Su J, Wang J, Liu X, Xu K, et al. EZH2-mediated epigenetic suppression of GDF15 predicts a poor prognosis and regulates cell proliferation in non-small-cell lung cancer. Mol Ther Nucleic Acids. 2018;12:309–18.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhang Y, Wang X, Zhang M, Zhang Z, Jiang L, Li L. GDF15 promotes epithelial-to-mesenchymal transition in colorectal [corrected]. Artif Cells Nanomed Biotechnol. 2018;46:652–8.

CAS  PubMed  Article  Google Scholar 

Talreja O, Cassagnol M. Diltiazem. Treasure Island (FL): StatPearls Publishing: (2021). https://www.ncbi.nlm.nih.gov/books/NBK532937/.

Wong B-S, Chiu L-Y, Tu D-G, Sheu G-T, Chan T-T. Anticancer effects of antihypertensive L-type calcium channel blockers on chemoresistant lung cancer cells via autophagy and apoptosis. Cancer Manag Res. 2020;12:1913.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Alqudah MA, Alrababah BA, Mhaidat NM. Amlodipine inhibits cell proliferation and induces cell cycle arrest in colorectal cancer cells. Jordan J Pharm Sci. 2017;110:1–8.

Google Scholar 

Al-Malky HS, Osman A-MM, Damanhouri ZA, Alkreathy HM, Al Aama JY, Ramadan WS, et al. Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals. Cancer Cell Int. 2019;19:1–10.

CAS  Article  Google Scholar 

Chiu L-Y, Ko J-L, Lee Y-J, Yang T-Y, Tee Y-T, Sheu G-T. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines. Toxicol Lett. 2010;192:408–18.

CAS  PubMed  Article  Google Scholar 

Jiang P, Enomoto A, Takahashi M. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett. 2009;284:122–30.

CAS  PubMed  Article  Google Scholar 

Van Impe K, Bethuyne J, Cool S, Impens F, Ruano-Gallego D, De Wever O, et al. A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis. Breast Cancer Res. 2013;15:1–15.

Google Scholar 

Patergnani S, Danese A, Bouhamida E, Aguiari G, Previati M, Pinton P, et al. Various aspects of calcium signaling in the regulation of apoptosis, autophagy, cell proliferation, and cancer. Int J Mol Sci. 2020;21:8323.

CAS  PubMed Central  Article  Google Scholar 

Hardell L, Axelson O, Fredrikson M. Antihypertensive drugs and risk of malignant diseases. Lancet. 1996;348:542.

CAS  PubMed  Article  Google Scholar 

Kaplan NM. Do calcium antagonists cause cancer? Lancet. 1996;348:541–2.

CAS  PubMed  Article  Google Scholar 

Pahor M, Guralnik JM, Ferrucci L, Corti MC, Salive ME, Cerhan JR, et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet. 1996;348:493–7.

CAS  PubMed  Article  Google Scholar 

Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens. 1996;9:695–9.

CAS  PubMed  Article  Google Scholar 

Durham AC, Walton JM. Calcium ions and the control of proliferation in normal and cancer cells. Biosci Rep. 1982;2:15–30.

CAS  PubMed  Article  Google Scholar 

Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J. 1995;9:219–28.

CAS  PubMed  Article  Google Scholar 

Horton R. Do calcium antagonists cause cancer? Lancet. 1996;348:49.

Article  Google Scholar 

Grimaldi-Bensouda L, Klungel O, Kurz X, de Groot MC, Maciel Afonso AS, de Bruin ML, et al. Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD). BMJ Open. 2016;6:e009147.

PubMed  PubMed Central  Article  Google Scholar 

Wilson LE, D’Aloisio AA, Sandler DP, Taylor JA. Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women. Breast Cancer Res. 2016;18:61.

PubMed  PubMed Central  Article  Google Scholar 

Buchanan PJ, McCloskey KD. Ca V channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeutics. Eur Biophysics J. 2016;45:621–33.

CAS  Article  Google Scholar 

Cui C, Merritt R, Fu L, Pan Z. Targeting calcium signaling in cancer therapy. Acta Pharmaceutica Sin B. 2017;7:3–17.

Article  Google Scholar 

Diezel W, Gruner S, Diaz LA, Anhalt GJ. Inhibition of cutaneous contact hypersensitivity by calcium transport inhibitors lanthanum and diltiazem. J Investigative Dermatol. 1989;93:322–6.

CAS  Article  Google Scholar 

Donovan M, Cotter T. Caspase-independent photoreceptor apoptosis in vivo and differential expression of apoptotic protease activating factor-1 and caspase-3 during retinal development. Cell Death Differ. 2002;9:1220–31.

CAS  PubMed  Article  Google Scholar 

Westermann D, Knollmann BC, Steendijk P, Rutschow S, Riad A, Pauschinger M, et al. Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy. Eur J Heart Fail. 2006;8:115–21.

CAS  PubMed  Article  Google Scholar 

Wang J, Peng Q, Lin Q, Childress C, Carey D, Yang W. Calcium activates Nedd4 E3 ubiquitin ligases by releasing the C2 domain-mediated auto-inhibition. J Biol Chem. 2010;285:12279–88.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Mukherjee R, Das A, Chakrabarti S, Chakrabarti O. Calcium dependent regulation of protein ubiquitination - Interplay between E3 ligases and calcium binding proteins. Biochimica et Biophysica Acta Mol Cell Res. 2017;1864:1227–35.

留言 (0)

沒有登入
gif